On the other hand, if TNF-α inhibitors may cause an increase in body weight by impairing lipolysis, blocking TNF-α signaling could become a new strategy to treat skeletal muscle disorders with severely reduced weight loss, such as cancer cachexia (32). The gene discussed is TNF; the disease is skeletal muscle disorder.